Topic: tempol

Radiotherapy (RT) is the mainstay of brain cancer treatment due the generation of reactive oxygen species that cause double- and single-stranded DNA breaks. Although tumour cells are more radiosensitive, healthy cells are also subject to radiation damage, and as such therapeutic radiation can induce progressive cognitive decline. We investigated whether radiation-induced cognitive impairments could be prevented with the antioxidant tempol. Male C57BL/6 mice aged 27 weeks were administered either tempol (100mg/kg/day) or 0.9% saline for seven consecutive days via the I.P. route. One day after t